SCHEMBL4022312

SCHEMBL4022312

O=[PH2]OCOC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577556 0.75 — —
Ethylene SCHEMBL154102 0.72 ALDH1A1 (0.30) —
Charcoal, Activated SCHEMBL8437007 0.72 ALDH1A1 (0.30) —
Bicarbonate SCHEMBL26925127 0.72 CA1 (0.39) —
Methane SCHEMBL17726148 0.72 ALDH1A1 (0.30) —
SCHEMBL4563364 0.71 — —
Ethyne SCHEMBL23319710 0.69 — —
SCHEMBL10704809 0.69 ALDH1A1 (0.32) —
Lindane SCHEMBL2688197 0.69 — —
Urea SCHEMBL10321479 0.67 ALDH1A1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521439-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2009-04-21 — — US claimed
US-20070027117-A1 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders BISHOP RICHARD D 2007-02-01 — — US claimed
US-7141559-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2006-11-28 — — US claimed
EP-1551860-B1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2006-11-22 — — EP claimed
US-7521439-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2009-04-21 — — US disclosed
US-20070027117-A1 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders BISHOP RICHARD D 2007-02-01 — — US disclosed
US-7141559-B2 Glucocorticoid receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2006-11-28 — — US disclosed
EP-1551860-B1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2006-11-22 — — EP disclosed
EP-1551860-A1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2005-07-13 — — EP disclosed
US-20040235810-A1 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders ABBOTT LABORATORIES 2004-11-25 — — US disclosed
WO-2004000869-A1 GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2003-12-31 — — WO disclosed
Send feedback